Jingyi Zhu

5.3k citations
104 papers · 4.4k indexed · 1 hit paper · h-index 39

Jingyi Zhu

100 papers receiving 4.4k citations

Hit Papers

Preferential Cancer Cell Self-Recognition and Tumor Self-...4192016202620192022100200300400

Peers

Jingyi Zhu
Comparison fields: 5 of 124
  • Biomaterials 1.8k
  • Polymers and Plastics 735
  • Biomedical Engineering 2.3k
  • Molecular Biology 1.8k
  • Materials Chemistry 1.0k
Replace Zhiliang Cheng with:
Zhiliang Cheng United States
Shuaidong Huo China
Mohamed E. H. ElSayed United States
Jianbin Tang China
Jianbin Tang China
Wenwu Xiao China
Kazuko Toh Japan
Wei‐Hai Chen China
Xiao‐Jiao Du China
Huizhen Jia China
Jingyi Zhu relative to Zhiliang Cheng United States Zhiliang Cheng's profile →
Citations per field
00.5×1.5×
Zhiliang Cheng · 1×
Citations per year

Countries citing papers authored by Jingyi Zhu

Since Specialization
Citations

This map shows the geographic impact of Jingyi Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyi Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyi Zhu more than expected).

Fields of papers citing papers by Jingyi Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingyi Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyi Zhu. The network helps show where Jingyi Zhu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jingyi Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jingyi Zhu Line = papers co-authored together Jingyi Zhu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20250
4 20250
5 20242
6 20242
7 20241
8 20233
9 20226
10 202181
11 202123
12 202013
13 202025
14 201920
15 201982
16 201845
17 201718
18 201612
19 201332
20 201010

About Jingyi Zhu

Jingyi Zhu is a scholar working on Biomaterials, Polymers and Plastics and Biomedical Engineering, having authored 104 papers that have together received 4.4k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (30 papers), Nanoplatforms for cancer theranostics (30 papers), Dendrimers and Hyperbranched Polymers (21 papers), RNA Interference and Gene Delivery (17 papers), Advanced biosensing and bioanalysis techniques (17 papers), Photoreceptor and optogenetics research (11 papers), Radiopharmaceutical Chemistry and Applications (11 papers) and Graphene and Nanomaterials Applications (6 papers). The work is most often cited by research in Biomaterials (1.8k citations), Polymers and Plastics (735 citations) and Biomedical Engineering (2.3k citations). Jingyi Zhu has collaborated with scholars based in China, Portugal and United States. Frequent co-authors include Xiangyang Shi, Xian‐Zheng Zhang, Mingwu Shen, Qi Lei, Kai Han, Jun Feng, Diwei Zheng, Zhijuan Xiong, Ren‐Xi Zhuo and Shibo Wang. Their work appears in journals such as Journal of the American Chemical Society, Advanced Materials and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026